We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+16.74%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$538M
AUM Growth
+$46.1M
Cap. Flow
-$2.96M
Cap. Flow %
-0.55%
Top 10 Hldgs %
69.12%
Holding
28
New
6
Increased
5
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$14.1M
2
GH icon
Guardant Health
GH
+$13.1M
3
EXAS
Exact Sciences
EXAS
+$7.65M
4
TXG icon
10x Genomics
TXG
+$5.93M
5
HOWL icon
Werewolf Therapeutics
HOWL
+$4.08M

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$14.7M
2
IQV icon
IQVIA
IQV
+$12.1M
3
DHR icon
Danaher
DHR
+$10.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$10.5M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$5.95M

Sector Composition

Rank Sector Weight
1 Healthcare 97.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMCR icon
26
Immunocore
IMCR
$1.74B
$3.01M 0.56%
46,300
– –
LNTH icon
27
Lantheus
LNTH
$6.57B
$2.69M 0.5%
43,200
– –
ADPT icon
28
Adaptive Biotechnologies
ADPT
$4.04B
– –
-1,214,860
Closed -$5.95M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Eagle Health Investments held 28 positions worth $538M, up 9.4% from $492M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Eagle Health Investments's Q1 2024 filing shows 6 new, 5 increased, 9 reduced and 1 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 299,700 shares worth $14M. The largest sale was Alnylam Pharmaceuticals, an estimated $14.7M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 100% a quarter earlier.

  • Eagle Health Investments's largest Q1 2024 buy was Ultragenyx Pharmaceutical: 299,700 shares worth $14M.
  • Eagle Health Investments added most to Guardant Health in Q1 2024, an estimated $13.1M increase.
  • Eagle Health Investments's biggest Q1 2024 reduction was Alnylam Pharmaceuticals, cutting an estimated $14.7M.
  • Eagle Health Investments fully exited Adaptive Biotechnologies in Q1 2024, selling an estimated $5.95M.
  • Eagle Health Investments's ten largest holdings make up 69% of its $538M portfolio in Q1 2024.
  • Eagle Health Investments opened 6 new positions and closed 1 in Q1 2024.
  • Eagle Health Investments's portfolio value rose 9.4% quarter-over-quarter to $538M.

Based on Eagle Health Investments's 13F filing for Q1 2024, filed 14 May 2024.